A Comparative Randomized Study of Standard Doxorubicin and Cyclophosphamide Followed by Weekly Paclitaxel Vs. Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF Followed by Weekly Paclitaxel As Neoadjuvant Therapy For Inflammatory and Locally Advanced Breast Cancer.
Phase of Trial: Phase III
Latest Information Update: 29 Oct 2015
At a glance
- Drugs Cyclophosphamide (Primary) ; Doxorubicin (Primary) ; Filgrastim (Primary) ; Cyclophosphamide; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 05 Aug 2005 New trial record.